To advance China’s new industrialization agenda and accelerate breakthroughs in original and disruptive biomanufacturing technologies, the Ministry of Industry and Information Technology of the PRC (MIIT) launched a national selection program for “Flagship Biomanufacturing Products.”
On June 24, the 23rd China World Pharmaceutical Ingredients Exhibition (CPHI China 2025) opened in grand fashion at Shanghai New International Expo Centre.
On April 7, 2025, China's Central Committee and the State Council released the Plan for Accelerating the Building of an Agricultural Powerhouse (2024-2035).
According to a recent announcement on the National Medical Products Administration (NMPA) website, Haikou Qili Pharmaceutical has received approval for its supplemental application for the consistency evaluation of Piperacillin Sodium and Tazobactam Sodium for injection.
Researchers at the Harvard T.H. Chan School of Public Health have found that replacing animal protein with plant protein is closely associated with a lower risk of cardiovascular disease (CVD) and coronary heart disease (CHD).
On September 15, China’s State Council released guidelines on developing a more diversified food-supply system under the “Big Food Concept,” encouraging the use of broader biological resources and the development of new food technologies.
![[Oriental Smart Manufacturing, Taste of the East and West] The 2025 Milan International Food Exhibition concluded successfully, Fushine brought](https://cloud-1251007531.bcdn8.com/fuxiang0611/uploads/20250630/0f9ff888dda832c1f4e55b1643528819.jpg)
